Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-06-29
1999-10-12
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530350, 530399, 530427, A61K 3818, A61K 3816, C07K 14435, C07K 14475
Patent
active
059655224
ABSTRACT:
The invention relates to a novel formulation of stem cell factor. The formulation contains histidine, glutamic acid, sucrose and mannitol. The formulation has a pH between 5.0 and 6.0 and has been lyophilized.
REFERENCES:
patent: 4877608 (1989-10-01), Lee et al.
patent: 5192743 (1993-03-01), Hsu et al.
Hora, et al. Developments in Biological Standardization, vol. 74, Karger, Basel, (1992).
Laemmli, Nature 227:680-685 (1970).
Seguro, Cryobiology 27: 70-79 (1990).
Amgen Inc.
Degen Nancy
Knight Matthew W.
Levy Ron K.
Pessin Karol M.
LandOfFree
Stem cell factor formulations and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem cell factor formulations and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cell factor formulations and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652355